Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies.

about

Foamy macrophage responses in the rat lung following exposure to inhaled pharmaceuticals: a simple, pragmatic approach for inhaled drug development.Differential cytotoxicity responses by dog and rat hepatocytes to phospholipogenic treatments.

P2860

Q38182903-42BEC694-48C5-4A84-A693-19E04310773B Q39374963-E8C0E544-0BA8-4D1E-8982-A4E6DBE33ED5

P2860

Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies.

Item

http://www.wikidata.org/entity/Q42213351

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@en

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@nl

type

Item

label

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@en

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@nl

prefLabel

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@en

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@nl

P1476

Phospholipogenic pharmaceutica ...... reclinical toxicology studies.

@en

P2093

James Fikes

http://www.w3.org/2001/XMLSchema#string

James R Damewood

http://www.w3.org/2001/XMLSchema#string

Linda R Barone

http://www.w3.org/2001/XMLSchema#string

Paul J Ciaccio

http://www.w3.org/2001/XMLSchema#string

Scott Boyer

http://www.w3.org/2001/XMLSchema#string

P2860

Drug-induced phospholipidosis: issues and future directions

Drug-induced phospholipidosis

Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities

Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping

Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.

The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.

Validation of an in vitro screen for phospholipidosis using a high-content biology platform.

Aminoglycosides: nephrotoxicity

Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.

Drug-induced phospholipidosis: are there functional consequences?

P304

308594

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/308594

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228089465

http://www.w3.org/2001/XMLSchema#string

P698

22745636

http://www.w3.org/2001/XMLSchema#string

P932

3382391

http://www.w3.org/2001/XMLSchema#string

Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies.

about

P2860

P2860

Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932